45 results
8-K
EX-99.1
JAZZ
Jazz Pharmaceuticals plc
8 Jan 24
Results of Operations and Financial Condition
7:45am
diagnosed <22 yrs with AML (COG) JZP351 (Vyxeos) Epilepsy 4 Low Intensity Dosing for higher risk MDS Suvecaltamide (JZP385) Undisclosed targets
DFAN14A
r3p0u l9hez
26 Feb 21
Additional proxy materials by non-management
12:00am
8-K
EX-99.1
pxr1gde54s5 k4g
4 Feb 21
Entry into a Material Definitive Agreement
12:00am
DFAN14A
gbz0cdhe1 7jv
4 Feb 21
Additional proxy materials by non-management
12:00am